Development of a next-generation chikungunya virus vaccine based on the HydroVax platform

por Slifka, Dawn K., Raué, Hans-Peter, Weber, Whitney C., Andoh, Takeshi F., Kreklywich, Craig N., DeFilippis, Victor R., Streblow, Daniel N., Slifka, Mark K., Amanna, Ian J.
Publicado 2022

An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001...

por Woods, Christopher W., Sanchez, Ana M., Swamy, Geeta K., McClain, Micah T., Harrington, Lynn, Freeman, Debra, Poore, Elizabeth A., Slifka, Dawn K., Poer DeRaad, Danae E., Amanna, Ian J., Slifka, Mark K., Cai, Shu, Shahamatdar, Venus, Wierzbicki, Michael R., Amegashie, Cyrille, Walter, Emmanuel B.
Publicado 2019